These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9438390)

  • 21. [Thanatophoric dysplasia].
    Tonoki H
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):294-5. PubMed ID: 11057234
    [No Abstract]   [Full Text] [Related]  

  • 22. Ligand-independent activation of tyrosine kinase in fibroblast growth factor receptor 1 by fusion with beta-galactosidase.
    Kouhara H; Kurebayashi S; Hashimoto K; Kasayama S; Koga M; Kishimoto T; Sato B
    Oncogene; 1995 Jun; 10(12):2315-22. PubMed ID: 7784079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G370C mutation in the FGFR3 gene in a Japanese patient with thanatophoric dysplasia.
    Katsumata N; Kuno T; Miyazaki S; Mikami S; Nagashima-Miyokawa A; Nimura A; Horikawa R; Tanaka T
    Endocr J; 1998 Apr; 45 Suppl():S171-4. PubMed ID: 9790257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane, and kinase domains.
    Neilson KM; Friesel R
    J Biol Chem; 1996 Oct; 271(40):25049-57. PubMed ID: 8798788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia.
    Webster MK; Donoghue DJ
    EMBO J; 1996 Feb; 15(3):520-7. PubMed ID: 8599935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Some chondrodysplasias with short limbs: molecular perspectives.
    Cohen MM
    Am J Med Genet; 2002 Oct; 112(3):304-13. PubMed ID: 12357475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sustained ERK1/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells.
    Nowroozi N; Raffioni S; Wang T; Apostol BL; Bradshaw RA; Thompson LM
    Hum Mol Genet; 2005 Jun; 14(11):1529-38. PubMed ID: 15843401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constitutive receptor activation by Crouzon syndrome mutations in fibroblast growth factor receptor (FGFR)2 and FGFR2/Neu chimeras.
    Galvin BD; Hart KC; Meyer AN; Webster MK; Donoghue DJ
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7894-9. PubMed ID: 8755573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast growth factor receptor 3 and the human chondrodysplasias.
    Horton WA
    Curr Opin Pediatr; 1997 Aug; 9(4):437-42. PubMed ID: 9300204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Thanatophoric dysplasia: three patients hospitalized in PAIP in 1994-2000].
    Kruczek A; Kruczek P; Mitkowska Z; Pietrzyk JJ
    Przegl Lek; 2002; 59 Suppl 1():137-9. PubMed ID: 12108063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGF receptor mutations: dimerization syndromes, cell growth suppression, and animal models.
    Kannan K; Givol D
    IUBMB Life; 2000 Mar; 49(3):197-205. PubMed ID: 10868910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of FGF receptors by mutations in the transmembrane domain.
    Li Y; Mangasarian K; Mansukhani A; Basilico C
    Oncogene; 1997 Mar; 14(12):1397-406. PubMed ID: 9136983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced binding of FGF1 to mutant fibroblast growth factor receptor 3.
    Khnykin D; Olsnes S
    Growth Factors; 2006 Jun; 24(2):111-9. PubMed ID: 16801131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [From gene to disease; achondroplasia and other skeletal dysplasias due to an activating mutation in the fibroblast growth factor].
    van Ravenswaaij-Arts CM; Losekoot M
    Ned Tijdschr Geneeskd; 2001 Jun; 145(22):1056-9. PubMed ID: 11414167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand-independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations.
    Lorenzi MV; Castagnino P; Chen Q; Chedid M; Miki T
    Oncogene; 1997 Aug; 15(7):817-26. PubMed ID: 9266968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid detection of common mutations of the FGFR3 gene causing thanatophoric dysplasia type I: two case reports.
    Yang Y; Liu YN; Li DZ
    Fetal Pediatr Pathol; 2012 Jun; 31(3):128-33. PubMed ID: 22414243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatic and germline mosaicism for a R248C missense mutation in FGFR3, resulting in a skeletal dysplasia distinct from thanatophoric dysplasia.
    Hyland VJ; Robertson SP; Flanagan S; Savarirayan R; Roscioli T; Masel J; Hayes M; Glass IA
    Am J Med Genet A; 2003 Jul; 120A(2):157-68. PubMed ID: 12833394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term survival in typical thanatophoric dysplasia type 1.
    Baker KM; Olson DS; Harding CO; Pauli RM
    Am J Med Genet; 1997 Jun; 70(4):427-36. PubMed ID: 9182787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations causing achondroplasia and thanatophoric dysplasia alter bFGF-induced calcium signals in human diploid fibroblasts.
    Nguyen HB; Estacion M; Gargus JJ
    Hum Mol Genet; 1997 May; 6(5):681-8. PubMed ID: 9158142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FGFR3 mutation in thanatophoric dysplasia type 1 with bilateral cystic renal dysplasia: coincidence or a new association?
    Prontera P; Sensi A; Pilu G; Baldi M; Baffico M; Bonasoni R; Calzolari E
    Genet Couns; 2006; 17(4):407-12. PubMed ID: 17375526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.